Study on Small Cell Lung Cancer Survival and Immunohistochemistry
Author Information
Author(s): L.G. Bobrow, F.R. Hirsch, F.G. Hay, L. Happerfield, B.G. Skov, K. Law, R.C.F. Leonard, R.L. Souhami
Primary Institution: University College and Middlesex School of Medicine
Hypothesis
Can immunohistochemical analysis of biopsy specimens provide prognostic information for small cell lung cancer patients?
Conclusion
Immunohistochemical analysis of biopsy specimens does not provide prognostic information in small cell lung cancer.
Supporting Evidence
- Immunohistochemical analysis failed to identify any antigen correlated with prognosis.
- Long-term survivors and short-term survivors were matched for age and sex.
- Only 70 out of 186 biopsy samples were suitable for analysis.
Takeaway
The study looked at cancer samples from patients who lived a long time or died quickly, but found that the tests didn't help predict how well they would do.
Methodology
The study analyzed biopsy specimens from patients with small cell lung cancer, comparing those who survived more than 2 years with those who died within 3 months.
Potential Biases
Potential biases in retrospective analyses and treatment effects were acknowledged.
Limitations
The study primarily used fibre-optic biopsy specimens, which may not represent the entire tumor.
Participant Demographics
Patients included both long-term survivors (LTS) and short-term survivors (STS) matched for age and sex.
Want to read the original?
Access the complete publication on the publisher's website